From the publishers of JADPRO

MPN Resource Center

Advertisement

Second cancer onset in myeloproliferative neoplasms: what, when, why?

This review highlights the risk of developing a second, solid cancer among patients with myeloproliferative neoplasms (MPNs), as well as possible links between MPNs and solid cancers including genetic susceptibility, the impact of cytotoxic therapies, the role of chronic inflammation, and immune deregulation.

International Journal of Molecular Sciences
Advertisement
News & Literature Highlights
Advertisement
Advertisement